Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.

Upcoming Meetings

SNMMI Therapeutics Conference: Therapies, Theranostics, and Building Your Radionuclide Clinical Practice

October 25-27, 2019 | Las Vegas, Nevada 
Book Your HotelAgenda | Register

Explore the Latest Innovations in Therapy
This two-and-a-half-day conference explores the latest innovations in therapy, including acquiring the knowledge and resources to effectively deliver theranostics agents and the fundamental steps necessary to establish a nuclear medicine therapy program at your institution.

PET-MRI Workshop

October 26-28, 2019 | New York, New York
Contact me when information becomes available. |Registration coming soon.

This joint workshop, presented by the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) PET Center of Excellence and International Society for Magnetic Resonance in Medicine (ISMRM), will focus on both the technical aspects of PET/MRI as well as the clinical utility of PET/MRI. The workshop will feature a mixture of invited scientific presentations, proffered papers, a poster session, small group discussion, and a keynote lecture. A young investigator award will be presented to students and early stage post-doctoral or physicians that will be selected from the oral paper presentations.

New! PET-MRI Workshop Call for Abstracts

Radiologists and nuclear medicine physicians, scientists, physicists, pre- and post-doctoral students, and technologists are invited to submit an original abstract that reflects their research and academic efforts specific to PET/MRI. Submit an abstract.

Coding and Reimbursement

The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.

For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.

For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.

Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!

Dose Optimization

In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.

SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.



The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.

View Guidelines.

Focusing on the Future of Molecular Imaging

SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.

Access resources.

The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.

Educational Offerings

SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors. 

Visit the SNMMI Learning Center.

Additional Resources

  • July 17, 2019Bipartisan Group Moves to Expand Access to Diagnostic Radiopharmaceuticals

    On July 16, a bipartisan group introduced the Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (HR 3772). The bill would expand patient access to highly targeted, precision diagnostic radiopharmaceuticals that evaluate conditions such as Alzheimer’s disease, Parkinson’s disease, and some cancers—allowing patients to get the right treatment faster and saving taxpayers money.
    (Press Release)

  • July 1, 2019This Month in JNM

    In July JNM: A discussion between Susanne Schaffert and Ken Herrmann … featured articles: immuno-PET imaging of solid tumors; a first-in-human phase I study of CTT1057 in prostate cancer … State of the Art—theranostics in neuroendocrine neoplasms … Hot Topic—imaging of CAR T-cells in cancer patients … Special Contribution—procedure standard for somatostatin receptor-based PRRT with 177Lu-DOTATATE … Continuing Education—advanced imaging in cardiac sarcoidosis … and more.
    (SNMMI News)

  • June 27, 2019Influence of The Journal of Nuclear Medicine Jumps 25 Percent

    The Journal of Nuclear Medicine again ranks among the top five medical imaging journals in the world. JNM continues to lead among nuclear medicine journals, with the highest impact factor (7.354), the highest immediacy index, the highest number of citations, the highest 5-year impact factor, the highest number of citable articles, and the highest influence score.
    (Press Release)

  • June 25, 2019New Combination Therapy Established as Safe and Effective for Prostate Cancer

    A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects.
    (Press Release)


SNMMI's Virtual Meeting

Get instant access to more than 100 sessions from the 2019 Annual Meeting.

Plus, through July 31, we're extending the special onsite pricing offered exclusively during the 2019 everyone!

Order now and view this valuable content at your own pace, on your own device, when it's convenient for you.

Order today.

Featured Resources